Exploring real-world experiences of early PrEP adopters in southern Germany

Plomer, Anna-Sophie; McCool-Myers, Megan; Apfelbacher, Christian

doi:10.1080/09540121.2021.1876835

Cited by 2 publications

(11 citation statements)

References 17 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…22,31,32,39 There were 3/74 (4%) instances of two themes: decreased substance use, which included a decrease in drug cravings, [21][22][23] and an increased quality of life, which included peace of mind or increased confidence to enjoy a sex life. 44,45,51 There were 2/74 (3%) instances of four themes: decreased PLHIV stigma 36,44 and decreased interpersonal problems, which included fewer discordant relationships, 20,50 highlighting a digital literacy gap 41,48 and security or privacy concerns. 41,48 The last two results are also listed as barriers to adoption.…”

Section: Results Of Interventions Compared With Control Groupsmentioning

confidence: 99%

“…The intervention frees the patient from a typical HIV stigma usually felt when visiting the clinic occurred 23/119 (19%) times. 20,23,[28][29][30][31][32][33][34][35][36][37][38][39][40][41][42][43][44][45][49][50][51] There were 15/119 (13%) instances of improvements in medical conditions, which included the following: weight loss, chills, sweats, fever, neuropathy, fatigue, genital tract inflammation, anxiety, depression,…”

Section: Results Themes and Observations Frequencymentioning

confidence: 99%

“…As established in the literature, a summary table is provided in Table 1: PICOS (participants, intervention, comparison (to control or other group), observation, study design). Of the 32 studies analyzed over the 5-year period, two were from 2017, 20,21 five were from 2018, [22][23][24][25][26] ten were from 2019, [27][28][29][30][31][32][33][34][35][36] seven were from 2020, [37][38][39][40][41][42][43] five were from 2021, [44][45][46][47][48] and three were from 2022. [49][50][51] All the studies used adults as participants (>18).…”

Section: Study Characteristicsmentioning

confidence: 99%

“…Convenience 20-51 32 Meets a digital preference of patient 31 No HIV stigma usually associated with clinic visit 20,23,[28][29][30][31][32][33][34][35][36][37][38][39][40][41][42][43][44][45][49][50][51] 23…”

Section: Facilitator Themes and Observations Frequencymentioning

confidence: 99%

“…[21][22][23][24]29,31,34,38,47 There were 2/119 (2%) instances of two themes: ease of use, which included look and feel, 25 and increased quality of life, which included increased confidence to enjoy a sex life. 45,51 The following observations only occurred once in the literature: customizable messages, improved behaviors, increased health knowledge, and low healthcare utilization. 24,42,47,50 Barriers to the Intervention of mHealth for the Management of HIV Very few barriers were identified in the literature that could create a theme.…”

mentioning

confidence: 99%

See 4 more Smart Citations

Leveraging mHealth for the Treatment and Management of PLHIV

Kruse¹,

Pacheco²,

Rosenthal³

et al. 2023

RMHP

View full text Add to dashboard Cite

The objective of this systematic review was to analyze published literature from the last five years to assess facilitators and barriers to the adoption of mHealth as interventions to treat and manage HIV for PLHIV (people living with HIV). The primary outcomes were physical and mental conditions. The secondary outcomes were behavior based (substance use, care engagement, and healthy habits). Methods: Four databases (PubMed, CINAHL, Web of Science, and ScienceDirect) were queried on 9/2/2022 for peer-reviewed studies on the treatment and management of PLHIV with mHealth as the intervention. The review was conducted in accordance with the Kruse Protocol and reported in accordance with PRISMA 2020. Results: Five mHealth interventions were identified across 32 studies that resulted in improvements in physical health, mental health, care engagement, and behavior change. mHealth interventions offer both convenience and privacy, meet a digital preference, increase health knowledge, decrease healthcare utilization, and increase quality of life. Barriers are cost of technology and incentives, training of staff, security concerns, digital literacy gap, distribution of technology, technical issues, usability, and visual cues are not available over the phone. Conclusion: mHealth offers interventions to improve physical health, mental health, care engagement, and behavior for PLHIV. There are many advantages to this intervention and very few barriers to its adoption. The barriers are strong, however, and should be addressed through policy. Further research should focus on specific apps for younger versus older PLHIV, based on preferences and the digital literacy gap.

show abstract

Section: Results Of Interventions Compared With Control Groupsmentioning

confidence: 99%

Section: Results Themes and Observations Frequencymentioning

confidence: 99%

Section: Study Characteristicsmentioning

confidence: 99%

Section: Facilitator Themes and Observations Frequencymentioning

confidence: 99%

mentioning

confidence: 99%

See 3 more Smart Citations

Leveraging mHealth for the Treatment and Management of PLHIV

Kruse¹,

Pacheco²,

Rosenthal³

et al. 2023

RMHP

View full text Add to dashboard Cite

show abstract

Perceptions and experiences of daily and long-acting pre-exposure prophylaxis (PrEP) among MSM in India

Agarwal,

Núñez,

Hill

et al. 2024

PLOS Glob Public Health

View full text Add to dashboard Cite

Oral pre-exposure prophylaxis (PrEP) is an effective HIV prevention strategy with high efficacy. An increased willingness to use PrEP among at-risk Indian men who have sex with men (MSM) population has been reported; however, little is known about their real experiences that guide their key motivators, facilitators, and barriers with using oral and Long-Acting (LA) Injectable PrEP. We recruited participants (n = 18) through active MSM social media networks. The interviews were conducted using teleconferencing software. Interview topics included participants’ sources of knowledge, experiences accessing daily PrEP, safe-sex behaviors while on PrEP, barriers and facilitators around PrEP, long-term goals with PrEP, perceptions around LA PrEP, and discussion around decision-making to switch from oral PrEP to LA PrEP. Transcripts were coded according to interview topics, and key themes were analyzed using a topical data analysis approach. Participants (median age 28 years, ranging from 18 to 40) reported a high perceived risk of HIV. This increased perceived risk was a key motivator for oral PrEP uptake. Most participants shared that they accessed PrEP through non-profit organizations serving the MSM community, where doctor consultations and medication were either free or subsidized. Even when participants reported high adherence to oral PrEP, they expressed discontent with the requirement to take it daily. High condom usage was reported concomitantly with PrEP use among most participants, except for a few who preferred bareback sex. Participants shared that they would prefer to continue PrEP until they are in a monogamous, exclusive relationship. The cost and affordability remained recurring themes, and while participants could afford oral PrEP, they wished it was cheaper, making it more accessible to the community at large. Most participants did not have prior knowledge of LA injectable PrEP but welcomed the intervention, alluding to cost and availability as the key decision-making factors affecting switching. MSM from India we interviewed adopted oral PrEP as an additional HIV prevention strategy to condoms through non-profit and private channels. Cost and broader access remains a concern among the MSM community. More acceptability research about long-acting PrEP is needed among MSM in the Indian context, and it is recommended for government interventions to include oral PrEP groups at higher risk of HIV acquisition.

show abstract

Exploring real-world experiences of early PrEP adopters in southern Germany

Cited by 2 publications

References 17 publications

Leveraging mHealth for the Treatment and Management of PLHIV

Leveraging mHealth for the Treatment and Management of PLHIV

Perceptions and experiences of daily and long-acting pre-exposure prophylaxis (PrEP) among MSM in India

Contact Info

Product

Resources

About